Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,022,632
+$4,317,460 QoQ
Shares Held
42,309
+125.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#326
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Snowden Capital Advisors LLC holds $146,228,358 across 13 Drug Manufacturers - General names. AZN ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,065 | $32,462,575 | |
| 2 | ABBV |
AbbVie Inc.
|
120,256 | $30,261,219 | |
| 3 | JNJ |
Johnson & Johnson
|
109,396 | $27,783,302 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,291 | $18,669,893 | |
| 5 | AMGN |
Amgen Inc
|
39,480 | $14,296,497 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
42,309 | $8,022,632 | |
| 7 | NVS |
Novartis AG
|
22,603 | $3,542,342 | |
| 8 | PFE |
Pfizer Inc
|
125,051 | $3,011,228 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,022,632 | 42,309 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,705,172 | 18,787 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||